Injectable Chitosan Hydrogels Doped with 2D Peptide Nanosheet-Drug Conjugates for Glutathione-Responsive Sustained Drug Delivery
© 2024 Wiley‐VCH GmbH..
The development of novel and effective drug delivery systems aimed at enhancing therapeutic profile and efficacy of therapeutic agents is a critical challenge in modern medicine. This study presents an intelligent drug delivery system based on self-assembled two-dimensional peptide nanosheets (2D PNSs). Leveraging the tunable properties of amino acid structures and sequences, we design a peptide with the sequence of Fmoc-FKKGSHC, which self-assembles into 2D PNSs with uniform structure, high biocompatibility, and excellent degradability. Covalent attachment of thiol-modified doxorubicin (DOX) drugs to 2D PNSs via disulfide bond results in the peptide-drug conjugates (PDCs), which is denoted as PNS-SS-DOX. Subsequently, the PDCs are encapsulated within the injectable, thermosensitive chitosan (CS) hydrogels for drug delivery. The designed drug delivery system demonstrates outstanding pH-responsiveness and sustained drug release capabilities, which are facilitated by the characteristics of the CS hydrogels. Meanwhile, the covalently linked disulfide bond within the PNS-SS-DOX is responsive to intracellular glutathione (GSH) within tumor cells, enabling controlled drug release and significantly inhibiting the cancer cell growth. This responsive peptide-drug conjugate based on a 2D peptide nanoplatform paves the way for the development of smart drug delivery systems and has bright prospects in the future biomedicine field.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Chemistry (Weinheim an der Bergstrasse, Germany) - (2024) vom: 13. März, Seite e202400021 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Luan, Xin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chitosan hydrogels |
---|
Anmerkungen: |
Date Revised 10.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1002/chem.202400021 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369671031 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369671031 | ||
003 | DE-627 | ||
005 | 20240411232439.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240313s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/chem.202400021 |2 doi | |
028 | 5 | 2 | |a pubmed24n1372.xml |
035 | |a (DE-627)NLM369671031 | ||
035 | |a (NLM)38477386 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Luan, Xin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Injectable Chitosan Hydrogels Doped with 2D Peptide Nanosheet-Drug Conjugates for Glutathione-Responsive Sustained Drug Delivery |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 10.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024 Wiley‐VCH GmbH. | ||
520 | |a The development of novel and effective drug delivery systems aimed at enhancing therapeutic profile and efficacy of therapeutic agents is a critical challenge in modern medicine. This study presents an intelligent drug delivery system based on self-assembled two-dimensional peptide nanosheets (2D PNSs). Leveraging the tunable properties of amino acid structures and sequences, we design a peptide with the sequence of Fmoc-FKKGSHC, which self-assembles into 2D PNSs with uniform structure, high biocompatibility, and excellent degradability. Covalent attachment of thiol-modified doxorubicin (DOX) drugs to 2D PNSs via disulfide bond results in the peptide-drug conjugates (PDCs), which is denoted as PNS-SS-DOX. Subsequently, the PDCs are encapsulated within the injectable, thermosensitive chitosan (CS) hydrogels for drug delivery. The designed drug delivery system demonstrates outstanding pH-responsiveness and sustained drug release capabilities, which are facilitated by the characteristics of the CS hydrogels. Meanwhile, the covalently linked disulfide bond within the PNS-SS-DOX is responsive to intracellular glutathione (GSH) within tumor cells, enabling controlled drug release and significantly inhibiting the cancer cell growth. This responsive peptide-drug conjugate based on a 2D peptide nanoplatform paves the way for the development of smart drug delivery systems and has bright prospects in the future biomedicine field | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a DOX | |
650 | 4 | |a GSH response | |
650 | 4 | |a chitosan hydrogels | |
650 | 4 | |a drug delivery | |
650 | 4 | |a peptide nanodrug | |
650 | 4 | |a peptide nanosheets | |
700 | 1 | |a Hu, Huiqiang |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Danzhu |e verfasserin |4 aut | |
700 | 1 | |a He, Peng |e verfasserin |4 aut | |
700 | 1 | |a Sun, Zhengang |e verfasserin |4 aut | |
700 | 1 | |a Xi, Yongming |e verfasserin |4 aut | |
700 | 1 | |a Wei, Gang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Chemistry (Weinheim an der Bergstrasse, Germany) |d 1996 |g (2024) vom: 13. März, Seite e202400021 |w (DE-627)NLM09455398X |x 1521-3765 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:13 |g month:03 |g pages:e202400021 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/chem.202400021 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 13 |c 03 |h e202400021 |